| 产品描述: | 微溶于已烷、正辛醇,溶于甲醇、甲苯、丙酮,易溶于乙酸乙酯、乙腈、二氯甲烷 |
| 体内研究: |
Azoxystrobin (0.5, 1, 10 mg/kg; Azoxystrobin 溶液混干燕片口服; 每周 2 次; 21 天) 对 E. crypticus 肠道内的细菌和真菌群落具有剂量效应,可以诱导致病菌的生长、降低有益细菌的丰度并破坏肠道微生态的稳定性。 Azoxystrobin (0, 2, 25, 50 mg/kg) 能够抑制尿酶 (urease)、Invertase 和磷酸酶 (phosphatase) 的活性,改变土壤微生物群落的相对丰度。 |
| 参考文献: |
1. Enock Mpofu, et al. Azoxystrobin amine: A novel azoxystrobin degradation product from Bacillus licheniformis strain TAB7. Chemosphere. 2021 Jun;273:129663. 2. Bertelsen, J.R, et al. Fungicidal effects of azoxystrobin and epoxiconazole on phyllosphere fungi, senescence and yield of winter wheat. Plant Pathology, 50: 190-205.3. Wang X, et al. Fungicide azoxystrobin induced changes on the soil microbiome[J]. Applied Soil Ecology, 2020, 145: 103343.4. Zhang Q, et al. Oral azoxystrobin driving the dynamic change in resistome by disturbing the stability of the gut microbiota of Enchytraeus crypticus. J Hazard Mater. 2022 Feb 5;423(Pt B):127252. |
| 溶解性: |
微溶于已烷、正辛醇,溶于甲醇、甲苯、丙酮,易溶于乙酸乙酯、乙腈、二氯甲烷 |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
2.479 ml |
12.395 ml |
24.79 ml |
| 5 mM |
0.496 ml |
2.479 ml |
4.958 ml |
| 10 mM |
0.248 ml |
1.239 ml |
2.479 ml |
| 50 mM |
0.05 ml |
0.248 ml |
0.496 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |